Evaluated articles

Showing page 266 of 1181 pages of list content

Antibody responses to SARS‐CoV ‐2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti‐cancer therapies

This article has 8 authors:
1. Wei Yee Chan
2. Catherine Zhu
3. Emilie Sanchez
4. Rajeev Gupta
5. Adele K. Fielding
6. Asim Khwaja
7. Elspeth M. Payne
8. Jenny O'Nions
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 19, 2022Latest activity Apr 9, 2022
Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults

This article has 13 authors:
1. Frances H. Priddy
2. Michael Williams
3. Simon Carson
4. Brittany Lavender
5. Julia Mathieson
6. Chris Frampton
7. Nicole J. Moreland
8. Reuben McGregor
9. Georgia Williams
10. Maia Brewerton
11. Katie Gell
12. James Ussher
13. Graham Le Gros
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 1, 2022Latest activity Apr 9, 2022
Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition

This article has 12 authors:
1. Thandeka Nkosi
2. Caroline Chasara
3. Andrea O Papadopoulos
4. Tiza L Nguni
5. Farina Karim
6. Mahomed-Yunus S Moosa
7. Inbal Gazy
8. Kondwani Jambo
9. COMMIT-KZN-Team
10. Willem Hanekom
11. Alex Sigal
12. Zaza M Ndhlovu
This article has been curated by 1 group:
- Curated by eLife
  
  Evaluation Summary:
  
  The study shows that individuals with unsuppressed HIV infection had poorer T cell polyfunctionality and lower cross-reactive responses to SARS-CoV-2 variants compared to those who were HIV negative or aviremic. The conclusions of this paper are well supported by the data and will be of interest to clinicians, immunologists, and public health practitioners, particularly in Southern Africa.
  
  (This preprint has been reviewed by eLife. We include the public reviews from the reviewers here; the authors also receive private feedback with suggested changes to the manuscript. Reviewer #1 agreed to share their name with the authors.)
Reviewed by eLife, ScreenIT

This article has 6 evaluationsAppears in 2 listsLatest version Jul 26, 2022Latest activity Jun 27, 2022
Interleukin-6 as a predictor of early weaning from invasive mechanical ventilation in patients with acute respiratory distress syndrome

This article has 6 authors:
1. Kazuya Sakai
2. Mototsugu Nishii
3. Ryo Saji
4. Reo Matsumura
5. Fumihiro Ogawa
6. Ichiro Takeuchi
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 6, 2022Latest activity Apr 9, 2022
Costs, Reach, and Benefits of COVID-19 Pandemic Electronic Benefit Transfer and Grab-and-Go School Meals for Ensuring Youths’ Access to Food During School Closures

This article has 7 authors:
1. Erica L. Kenney
2. Lina Pinero Walkinshaw
3. Ye Shen
4. Sheila E. Fleischhacker
5. Jessica Jones-Smith
6. Sara N. Bleich
7. James W. Krieger
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 31, 2022Latest activity Apr 9, 2022
Delta-Omicron recombinant escapes therapeutic antibody neutralization

This article has 22 authors:
1. Ralf Duerr
2. Hao Zhou
3. Takuya Tada
4. Dacia Dimartino
5. Christian Marier
6. Paul Zappile
7. Guiqing Wang
8. Jonathan Plitnick
9. Sara B. Griesemer
10. Roxanne Girardin
11. Jessica Machowski
12. Sean Bialosuknia
13. Erica Lasek-Nesselquist
14. Samuel L. Hong
15. Guy Baele
16. Meike Dittmann
17. Mila B. Ortigoza
18. Prithiv J. Prasad
19. Kathleen McDonough
20. Nathaniel R. Landau
21. Kirsten St George
22. Adriana Heguy
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Feb 1, 2023Latest activity Apr 9, 2022
Delineating antibody escape from Omicron sublineages

This article has 13 authors:
1. Henning Gruell
2. Kanika Vanshylla
3. Michael Korenkov
4. Pinkus Tober-Lau
5. Matthias Zehner
6. Friederike Münn
7. Hanna Janicki
8. Max Augustin
9. Philipp Schommers
10. Leif Erik Sander
11. Florian Kurth
12. Christoph Kreer
13. Florian Klein
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 6, 2022Latest activity Apr 9, 2022
Racial/Ethnic, Biomedical, and Sociodemographic Risk Factors for COVID-19 Positivity and Hospitalization in the San Francisco Bay Area

This article has 2 authors:
1. Wendy K. Tam Cho
2. David G. Hwang
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 19, 2022Latest activity Apr 9, 2022
Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant

This article has 5 authors:
1. Sammy Huygens
2. Bas Oude Munnink
3. Arvind Gharbharan
4. Marion Koopmans
5. Bart Rijnders
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 22, 2022Latest activity Apr 9, 2022
From Alpha to Omicron BA.2: New digital RT-PCR approach and challenges for SARS-CoV-2 VOC monitoring and normalization of variant dynamics in wastewater

This article has 18 authors:
1. Sebastien Wurtzer
2. Morgane Levert
3. Eloïse Dhenain
4. Heberte Accrombessi
5. Sandra Manco
6. Nathalie Fagour
7. Marion Goulet
8. Nicolas Boudaud
9. Lucie Gaillard
10. Isabelle Bertrand
11. Julie Challant
12. Sophie Masnada
13. Sam Azimi
14. Miguel Gillon-Ritz
15. Alban Robin
16. Jean-Marie Mouchel
17. Obepine Sig
18. Laurent Moulin
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 1, 2022Latest activity Apr 9, 2022
Effect of heat inactivation and bulk lysis on real-time reverse transcription PCR detection of the SARS-COV-2: an experimental study

This article has 12 authors:
1. Dereje Leta
2. Gadissa Gutema
3. Gebremedhin Gebremichael Hagos
4. Regasa Diriba
5. Gutema Bulti
6. Tolawak Sura
7. Desta Ayana
8. Dawit Chala
9. Boki Lenjiso
10. Jaleta Bulti
11. Saro Abdella
12. Habteyes Hailu Tola
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Sep 7, 2022Latest activity Apr 9, 2022
SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022

This article has 12 authors:
1. Yosuke Hirotsu
2. Makoto Maejima
3. Masahiro Shibusawa
4. Yume Natori
5. Yuki Nagakubo
6. Kazuhiro Hosaka
7. Hitomi Sueki
8. Hitoshi Mochizuki
9. Toshiharu Tsutsui
10. Yumiko Kakizaki
11. Yoshihiro Miyashita
12. Masao Omata
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 1, 2022Latest activity Apr 9, 2022
SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein

This article has 3 authors:
1. Simone Parn
2. Kush Savsani
3. Sivanesan Dakshanamurthy
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Dec 1, 2022Latest activity Apr 8, 2022
ViReMaShiny : an interactive application for analysis of viral recombination data

This article has 2 authors:
1. Jason Yeung
2. Andrew L Routh
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 29, 2022Latest activity Apr 8, 2022
Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia

This article has 24 authors:
1. Daphne Day
2. Lisa Grech
3. Mike Nguyen
4. Nathan Bain
5. Alastair Kwok
6. Sam Harris
7. Hieu Chau
8. Bryan Chan
9. Richard Blennerhassett
10. Louise Nott
11. Nada Hamad
12. Annette Tognela
13. David Hoffman
14. Amelia McCartney
15. Kate Webber
16. Jennifer Wong
17. Craig Underhill
18. Brett Sillars
19. Antony Winkel
20. Mark Savage
21. Bao Sheng Loe
22. Daniel Freeman
23. Eva Segelov
24. on behalf of the CANVACCS, DIABVACCS and MSVACCS Investigators
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 26, 2022Latest activity Apr 8, 2022
Analysis of Immunization, Adverse Events, and Efficacy of a Fourth Dose of BNT162b2 Vaccine in Health Workers in Mexico, a Pilot Study

This article has 8 authors:
1. Maria Elena Romero-Ibarguengoitia
2. Arnulfo González-Cantú
3. Diego Rivera-Salinas
4. Yodira Guadalupe Hernández-Ruíz
5. Ana Gabriela Armendariz-Vázquez
6. Irene Antonieta Barco-Flores
7. Rosalinda González-Facio
8. Miguel Ángel Sanz-Sánchez
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 17, 2022Latest activity Apr 8, 2022
Predictors for reactogenicity and humoral immunity to SARS-CoV-2 following infection and mRNA vaccination: A regularized, mixed-effects modelling approach

This article has 13 authors:
1. Erin C. Williams
2. Alexander Kizhner
3. Valerie S. Stark
4. Aria Nawab
5. Daniel D. Muniz
6. Felipe Echeverri Tribin
7. Juan Manuel Carreño
8. Dominika Bielak
9. Gagandeep Singh
10. Michael E. Hoffer
11. Florian Krammer
12. Suresh Pallikkuth
13. Savita Pahwa
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Feb 9, 2023Latest activity Apr 8, 2022
Multiplexed biosensor for point-of-care COVID-19 monitoring: CRISPR-powered unamplified RNA diagnostics and protein-based therapeutic drug management

This article has 10 authors:
1. Midori Johnston
2. H. Ceren Ates
3. Regina T. Glatz
4. Hasti Mohsenin
5. Rosanne Schmachtenberg
6. Nathalie Göppert
7. Daniela Huzly
8. Gerald A. Urban
9. Wilfried Weber
10. Can Dincer
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Dec 1, 2022Latest activity Apr 8, 2022
An Ultralong Bovine CDRH3 that Targets a Conserved, Cryptic Epitope on SARS-CoV and SARS-CoV-2

This article has 6 authors:
1. Matthew J. Burke
2. James N.F. Scott
3. Thomas Minshull
4. Peter G. Stockley
5. Antonio N. Calabrese
6. Joan Boyes
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 6, 2022Latest activity Apr 8, 2022
Vascular inflammation exposes perivascular cells to SARS-CoV-2 infection

This article has 6 authors:
1. Cristiane Miranda Franca
2. Amin Mansoorifar
3. Avathamsa Athirasala
4. Ramesh Subbiah
5. Anthony Tahayeri
6. Luiz Bertassoni
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 6, 2022Latest activity Apr 8, 2022

Evaluated articles

Antibody responses to SARS‐CoV ‐2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti‐cancer therapies

Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults

Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition

Curated by eLife

Interleukin-6 as a predictor of early weaning from invasive mechanical ventilation in patients with acute respiratory distress syndrome

Costs, Reach, and Benefits of COVID-19 Pandemic Electronic Benefit Transfer and Grab-and-Go School Meals for Ensuring Youths’ Access to Food During School Closures

Delta-Omicron recombinant escapes therapeutic antibody neutralization

Delineating antibody escape from Omicron sublineages

Racial/Ethnic, Biomedical, and Sociodemographic Risk Factors for COVID-19 Positivity and Hospitalization in the San Francisco Bay Area

Sotrovimab Resistance and Viral Persistence After Treatment of Immunocompromised Patients Infected With the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant

From Alpha to Omicron BA.2: New digital RT-PCR approach and challenges for SARS-CoV-2 VOC monitoring and normalization of variant dynamics in wastewater

Effect of heat inactivation and bulk lysis on real-time reverse transcription PCR detection of the SARS-COV-2: an experimental study

SARS-CoV-2 Omicron sublineage BA.2 replaces BA.1.1: Genomic surveillance in Japan from September 2021 to March 2022

SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein

ViReMaShiny : an interactive application for analysis of viral recombination data

Serious Underlying Medical Conditions and COVID-19 Vaccine Hesitancy: A Large Cross-Sectional Analysis from Australia

Analysis of Immunization, Adverse Events, and Efficacy of a Fourth Dose of BNT162b2 Vaccine in Health Workers in Mexico, a Pilot Study

Predictors for reactogenicity and humoral immunity to SARS-CoV-2 following infection and mRNA vaccination: A regularized, mixed-effects modelling approach

Multiplexed biosensor for point-of-care COVID-19 monitoring: CRISPR-powered unamplified RNA diagnostics and protein-based therapeutic drug management

An Ultralong Bovine CDRH3 that Targets a Conserved, Cryptic Epitope on SARS-CoV and SARS-CoV-2

Vascular inflammation exposes perivascular cells to SARS-CoV-2 infection